Answers are grounded in this paper and cite their sources.
Thermally activated delayed fluorescence (TADF) and room-temperature phosphorescence (RTP) are two highly applicable emissive processes due to their time-resolved characteristics and their ability to respond to external stimuli. They have recently been integrated for comprehensive use in some solid-state luminogens; however, there remains a lack of molecular systems that can integrate them in the solution aggregated state, which considerably limits relevant biological applications. In this study, we present a molecular design enabling aggregation-induced TADF–RTP dual emission in the solution aggregated state, relying on the coexistence of T1-to-S1 and T1-to-S0 electronic processes in push–pull structures. This dual emission feature constitutes a broad spectral band with full width at half-maximum up to 175 nm, providing the ability to select different channels for biological detection and imaging. Moreover, deoxygenation is shown to promote molecular aggregation, leading to a significantly strengthened dual emission that enables a high-contrast hypoxia probing effect. These results not only reveal new photophysical mechanisms on organic molecules but also expand the detection functionality of luminescent materials in the biological field.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: